Russell Investments Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $951K | Buy |
113,425
+103,738
| +1,071% | +$1.09M | ﹤0.01% | 2238 |
|
|
2025
Q4 | $139K | Sell |
9,687
-1,488
| -13% | -$18.5K | ﹤0.01% | 2943 |
|
|
2025
Q3 | $108K | Sell |
11,175
-4,483
| -29% | -$39.6K | ﹤0.01% | 3005 |
|
|
2025
Q2 | $129K | Buy |
+15,658
| New | +$131K | ﹤0.01% | 2761 |
|
|
2024
Q4 | – | Sell |
-28,281
| Closed | -$297K | – | 3777 |
|
|
2024
Q3 | $297K | Buy |
28,281
+9,292
| +49% | +$113K | ﹤0.01% | 2418 |
|
|
2024
Q2 | $222K | Buy |
18,989
+10,527
| +124% | +$164K | ﹤0.01% | 2454 |
|
|
2024
Q1 | $178K | Sell |
8,462
-32,023
| -79% | -$570K | ﹤0.01% | 2466 |
|
|
2023
Q4 | $727K | Buy |
40,485
+291
| +0.7% | +$5.13K | ﹤0.01% | 2095 |
|
|
2023
Q3 | $662K | Sell |
40,194
-987
| -2% | -$17.9K | ﹤0.01% | 2123 |
|
|
2023
Q2 | $823K | Sell |
41,181
-10,563
| -20% | -$204K | ﹤0.01% | 2028 |
|
|
2023
Q1 | $978K | Buy |
51,744
+51,116
| +8,139% | +$1.13M | ﹤0.01% | 1974 |
|
|
2022
Q4 | $14.2K | Hold |
628
| – | – | ﹤0.01% | 2826 |
|
|
2022
Q3 | $16K | Sell |
628
-15,112
| -96% | -$448K | ﹤0.01% | 2831 |
|
|
2022
Q2 | $388K | Sell |
15,740
-2,320
| -13% | -$58K | ﹤0.01% | 2346 |
|
|
2022
Q1 | $598K | Buy |
18,060
+16,516
| +1,070% | +$459K | ﹤0.01% | 2166 |
|
|
2021
Q4 | $50K | Hold |
1,544
| – | – | ﹤0.01% | 2903 |
|
|
2021
Q3 | $64K | Sell |
1,544
-30,773
| -95% | -$1.11M | ﹤0.01% | 2926 |
|
|
2021
Q2 | $1.25M | Sell |
32,317
-2,124
| -6% | -$76K | ﹤0.01% | 2199 |
|
|
2021
Q1 | $1.17M | Buy |
34,441
+3,368
| +11% | +$144K | ﹤0.01% | 2176 |
|
|
2020
Q4 | $1.41M | Buy |
31,073
+23,638
| +318% | +$826K | ﹤0.01% | 1941 |
|
|
2020
Q3 | $204K | Buy |
7,435
+6,035
| +431% | +$197K | ﹤0.01% | 2771 |
|
|
2020
Q2 | $51K | Buy |
+1,400
| New | +$52.2K | ﹤0.01% | 2984 |
|
|
2019
Q4 | – | Sell |
-45,448
| Closed | -$1.61M | – | 3122 |
|
|
2019
Q3 | $1.61M | Sell |
45,448
-2,648
| -6% | -$107K | ﹤0.01% | 1792 |
|
|
2019
Q2 | $2.47M | Sell |
48,096
-17,000
| -26% | -$849K | ﹤0.01% | 1572 |
|
|
2019
Q1 | $3.67M | Buy |
65,096
+38,120
| +141% | +$1.89M | 0.01% | 1406 |
|
|
2018
Q4 | $1.13M | Sell |
26,976
-29,916
| -53% | -$1.75M | ﹤0.01% | 1884 |
|
|
2018
Q3 | $4.29M | Buy |
56,892
+54,695
| +2,490% | +$3.94M | 0.01% | 1372 |
|
|
2018
Q2 | $157K | Buy |
+2,197
| New | +$105K | ﹤0.01% | 2685 |
|
|
2017
Q3 | – | Sell |
-16,691
| Closed | -$330K | – | 2994 |
|
|
2017
Q2 | $330K | Sell |
16,691
-14,009
| -46% | -$271K | ﹤0.01% | 2565 |
|
|
2017
Q1 | $592K | Sell |
30,700
-31,441
| -51% | -$606K | ﹤0.01% | 2358 |
|
|
2016
Q4 | $1.14M | Buy |
+62,141
| New | +$1.19M | ﹤0.01% | 2108 |
|
Other funds holding RGNX
RG
VCM
IHAM
Russell Investments Group's RGNX Position: Q1 2026 in Review
Russell Investments Group increased its Regenxbio (RGNX) stake by 1,071% in Q1 2026, buying an estimated $1.09M and bringing the position to 113,425 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.
Russell Investments Group first reported a position in RGNX in Q4 2016 and has held it in 31 quarters since. The position peaked at $4.29M in Q3 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Russell Investments Group held 113,425 shares of Regenxbio worth $951K as of Q1 2026.
- Russell Investments Group bought 103,738 Regenxbio shares in Q1 2026, an estimated $1.09M.
- Regenxbio made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2238 holding.
- Russell Investments Group first reported a position in Regenxbio in Q4 2016 and has held it in 31 quarters since.
- Russell Investments Group's Regenxbio position peaked at $4.29M in Q3 2018.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.